Urothelial cancer
51 – 60 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires
- Contribution to journal › Article
-
Mark
What is a Bladder Cancer Molecular Subtype?
- Contribution to journal › Scientific review
- 2022
-
Mark
Urostomal ileal conduit complications in association with abdominal wall mesh implantation
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
- Contribution to journal › Scientific review
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
- Contribution to journal › Article
-
Mark
A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
- Contribution to journal › Article
-
Mark
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
- Contribution to journal › Article
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
- Contribution to journal › Article
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
- Contribution to journal › Article
